PODD
Insulet Corp. · Healthcare · Medical - Devices
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -0.7% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | 0 | 52.88M | $8.06B | +7 | −8 |
| Q1 2026 | 162 | -3 | 53.76M | $11.28B | +2 | −6 |
| Q4 2025 | 164 | +1 | 61.46M | $17.44B | +2 | n/a |
| Q3 2025 | 24 | +1 | 35.22M | $10.87B | +1 | −1 |
| Q2 2025 | 21 | -2 | 34.19M | $10.74B | n/a | −2 |
| Q1 2025 | 20 | +1 | 10.99M | $2.88B | +1 | n/a |
| Q4 2024 | 19 | 0 | 11.49M | $3.00B | +1 | −1 |
| Q3 2024 | 18 | 0 | 8.60M | $2.00B | +1 | −1 |
| Q2 2024 | 18 | n/a | 10.07M | $2.03B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 2.97M | n/a | $776.57M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Baillie Gifford ✦ | 2.36M | +3.5% | $615.00M | 0.5% | ▲ Add | 3 | SEC ↗ ×4 |
| 3 | Geode Capital Management ✦ (pasivo) | 1.78M | +2.3% | $463.35M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (pasivo) | 953.02K | +7.4% | $248.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 729.11K | -26.4% | $190.35M | 0.2% | ▼ Trim | 3 | SEC ↗ ×2 |
| 6 | PRIMECAP Management ✦ | 493.22K | -10.7% | $128.76M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Marshall Wace ✦ | 486.52K | +29.6% | $127.01M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Fisher Asset Management ✦ | 377.69K | +7.6% | $98.60M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 325.33K | -3.5% | $84.93M | 0.0% | ▼ Trim | 3 | SEC ↗ ×8 |
| 10 | T. Rowe Price ✦ | 202.73K | +0.4% | $52.93M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 11 | Capital World Investors ✦ | 168.00K | 0.0% | $43.86M | 0.0% | Held | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 158.99K | +45.7% | $41.51M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 158.13K | -8.4% | $41.28M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 14 | Adage Capital Partners ✦ | 155.50K | -39.6% | $40.60M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 100.16K | -18.8% | $26.15M | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
| 16 | Arrowstreet Capital ✦ | 37.62K | Nuevo | $9.82M | 0.0% | New | 1 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 16.98K | -56.6% | $4.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 7.73K | -30.6% | $2.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 6.83K | +57.2% | $1.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Arrowstreet Capital | $9.82M | 0.0% |
Posición cerrada
| D. E. Shaw & Co. | $269,525 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 779 tenedores, 69.27M acciones, $13.82B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Officer, Director · President and CEO · 1.10K acc. @ 147.47 · $162,217
Ventas en mercado abierto (S)
Sin ventas en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología